BCL2 and gastrointestinal disease: Among the gastric cancer-related targets, B-Cell CLL/Lymphoma 2 (BCL2)16, Caspase 3 (CASP3)17, interleukin-10 (IL-10), nitric oxide synthase, inducible (NOS2), nuclear factor kappa-B (NFκB), Cyclooxygenase 2 (COX2)18 and other proteins were involved in the immunoregulation, apoptosis and inflammatory processes of gastrointestinal diseases, which may indicate the synergistic effect of compounds and targets on gastric cancer.